Skip to main content
. 2022 Aug 31;13:973116. doi: 10.3389/fphar.2022.973116

FIGURE 6.

FIGURE 6

MYC expression profile in NAFLD. (A) Difference was analyzed in the expression of MYC between different clinical stages of NAFLD. The ANOVA was performed to the difference among the multiple clinical stages. Turkey’s post hoc test was used for comparison between groups. (B) Correlations between the expression of MYC and patients’ clinical characteristics. The correlations were all analyzed by Pearson’s test except for fibrosis, lobular inflammation, and ballooning. The correlations between the MYC expression and the characteristic of fibrosis, lobular inflammation, and ballooning were conducted by Spearman’s test. The results of significant difference analysis: ns ≥ 0.05; *p < 0.05; **p < 0.01; and ***p < 0.001.